Bone marrow transplant (BMT) and stem cell transplant programs are among the most administratively complex subspecialty services in oncology. A single allogeneic transplant from identification of a suitable candidate through day +100 follow-up involves dozens of discrete administrative tasks: HLA typing coordination, NMDP donor search initiation and management, pretransplant workup scheduling across multiple departments, FACT accreditation documentation, and systematic post-transplant follow-up scheduling. Transplant coordinators — typically advanced practice nurses or RNs — are the backbone of these programs, but the non-clinical coordination and documentation work they absorb is increasingly being offloaded to trained virtual assistants (VAs), freeing coordinators for the patient-facing, clinically complex work that requires their credentials.
HLA Typing Coordination
HLA typing is the first step in evaluating whether a patient is a candidate for allogeneic transplantation and, if so, what donor options are available. High-resolution HLA typing at the A, B, C, DRB1, and DQB1 loci is now standard, and the process requires blood draw coordination, specimen packaging for reference lab shipment, and result tracking. For patients requiring urgent evaluation — particularly those with AML in remission who have a narrow transplant window — HLA typing turnaround time directly affects whether the transplant timeline is clinically achievable.
VAs coordinate HLA typing specimen collection by scheduling blood draws, confirming specimen handling requirements with the reference laboratory, arranging shipping logistics, and tracking result turnaround. The Foundation for the Accreditation of Cellular Therapy (FACT) requires that HLA typing results be documented in the patient record as part of the pre-transplant evaluation file, and VAs ensure this documentation is complete and properly filed.
Donor Search Management
For patients without a matched sibling donor, the NMDP/Be The Match registry search is the primary pathway to finding an unrelated donor. The search process involves submitting patient HLA data to the NMDP, reviewing preliminary search results, identifying potential donors for confirmatory typing, managing workup requests, and — when a donor is selected — coordinating the donor medical evaluation, collection scheduling, and product transport logistics. Each of these steps involves communication between the transplant program, the NMDP, and the donor center, and the timeline must be tracked against the patient's clinical treatment plan.
VAs manage donor search tracking: monitoring NMDP portal communications, tracking workup request status for potential donors, flagging timeline concerns to the transplant coordinator, and documenting donor search status updates in the patient record. For programs conducting 30 or more unrelated donor transplants annually, this coordination layer is a full-time function.
FACT Accreditation Documentation
FACT accreditation is required for BMT programs seeking recognition by major payers and CMS-certified cancer programs. FACT standards cover clinical program oversight, cellular therapy product handling, patient evaluation and consent, adverse event tracking, and long-term follow-up. At each accreditation survey, FACT inspectors review patient records for documentation completeness — including pre-transplant evaluation checklists, informed consent documentation, product labeling records, and adverse event reports.
VAs maintain FACT documentation compliance by auditing patient records against pre-transplant evaluation checklists, ensuring all required consents are obtained and filed, tracking adverse event documentation to confirm timely reporting, and preparing records for annual FACT data submission. According to FACT's 2024 accreditation report, documentation deficiencies were cited in 34% of transplant program surveys — a rate that structured VA documentation management directly reduces.
Day +30, +60, +100, and One-Year Follow-Up Scheduling
Post-transplant follow-up visits are clinically critical: they monitor for graft-versus-host disease, infection, engraftment durability, and disease response. Day +100 is a major milestone — the timepoint at which disease status evaluation, chimerism testing, and formal GVHD assessment typically occur. Missing or delayed post-transplant follow-up visits create both safety risks and FACT documentation gaps.
VAs maintain post-transplant follow-up calendars for all active patients, generating visit schedules from the day-zero transplant date, sending patient reminders, coordinating with referring hematologists for shared care, and tracking completion of required lab studies at each follow-up timepoint. Programs using VA support for post-transplant follow-up coordination report significantly higher visit compliance rates than programs relying on coordinator-only recall.
Transplant programs seeking to build this coordination infrastructure can visit Stealth Agents for BMT-trained virtual assistants.
Sources
- Foundation for the Accreditation of Cellular Therapy. "FACT Accreditation Standards." factwebsite.org. 2024.
- National Marrow Donor Program. "Be The Match Transplant Program Operations." bethematch.org. 2024.
- Blood and Marrow Transplant Clinical Trials Network. "BMT CTN Program Operations Report." 2023.
- American Society for Transplantation and Cellular Therapy. "ASTCT Workforce Survey." 2024.